Horizon Europe · MISSHORIZON Coordination and Support Actions

Development of a research capacity building programme on cancer with and for Ukraine

Deadline15 September 2026
Total budget€5M
Grant size€5M
Expected grants1
Opens10 February 2026
Deadline modelsingle-stage
Call IDHORIZON-MISS-2026-02

What this call funds

Expected Outcome

This topic aims to develop a wide capacity building programme between EU Member States/Associated Countries and Ukrainian cancer centres, to support improvement or development of research & innovation-related capacities and integration with cancer care.

To this end, proposals should aim at delivering results that are directed and tailored towards and contribute to all of the following expected outcomes:

  • Researchers, clinicians and health care professionals will have access to improved research capacities, supporting better integration with care.
  • Patients and citizens will have access to improved screening, diagnostics and treatments, while increasing their participation in clinical trials.

Scope

Ukraine has a very high cancer burden with more than 155,000 new diagnoses every year[1]. The country has also one of the highest childhood cancer mortality rates globally[2]. Disparities in access and quality of cancer care in Ukraine were high before Russia's unprovoked aggression and worsened because of the conflict, which has also led to increased cancer mortality and morbidity, due to discontinuation of treatments and shortage of medical supplies.

Proposals should address all of the following:

A research capacity-building programme should be set up between EU Member States/Associated Countries and Ukraine, in order to support Ukraine to develop or to further improve research & innovation-related capacities of future or existing Cancer Infrastructures.

The capacity building programme should include the following components:

  • Development of a joint-research training programme, including distance-learning modules
  • Twinning research activities, including staff-exchange for the implementation of targeted research projects and access to cutting-edge services

The capacity building programme should cover at least the following areas;

  • Enhanced involvement in quality scientific research, including development and implementation of clinical trials and other epidemiological studies and related training[3];
  • Better integration of research and care to improve patient outcomes. Particular emphasis should be given to cancer in children, adolescents and young adults;
  • Improvement of digital capacity to support primary and secondary use of patient data, including through improvement of data exchange capacities[4] and development of cancer registries where needed.

Gender-related aspects, with respect to representation in research and career pathways and any other relevant aspects, should be duly taken into account.

The research capacity-building programme should be tailored to the needs of the participating entities. This concerns in particular the required participants / stakeholder groups, duly reflecting health and research system specificities. The training module shall consist of balanced theoretical and practical parts, including simulations, case studies, group exercises, mutual learning exercises and on-site visits (when possible) to gather practical experience. Safety of participating staff/researchers should be prioritised.

Advantage should be taken to the extent possible of experience gained under current and previous initiatives such as CCI4EU[5], Jane[6], Jane 2[7], Crane[8], CanSERV[9] and others. The relevant EU research infrastructures in the life science domain[10] and other EU initiatives should be exploited for available research services, as appropriate.

[1] 04-ukraine-fact-sheet.pdf

[2] 9789289057615-eng.pdf

[3] Topics to be covered include but are not limited to study design, process of trial approval, ethical aspects, recruitment, staffing and training requirements including digital skills, data management and data analysis, organisational aspects, regulatory requirements, clinical core facilities, patient participation and empowerment

[4] e.g. interoperability of standards, data protection related aspects and others as appropriate

[5] CCI4EU

[6] Shaping the EU Networksof Expertise on cancer!

[7] Home - Jane 2

[8] CraNE4Health European Network of Comprehensive Cancer Centres

[9] canSERV - Cutting Edge Cancer Research Services Across Europe

[10] Home | LifeScience

Eligibility & conditions+

General conditions

1. Admissibility Conditions: Proposal page limit and layout

described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.

2. Eligible Countries

described in Annex B of the Work Programme General Annexes.

A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other Eligible Conditions

Subject to restrictions for the protection of European communication networks.

described in Annex B of the Work Programme General Annexes.

4. Financial and operational capacity and exclusion

described in Annex C of the Work Programme General Annexes.

5a. Evaluation and award: Award criteria, scoring and thresholds

are described in Annex D of the Work Programme General Annexes.

5b. Evaluation and award: Submission and evaluation processes

The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 4 (Implementation). The cumulative threshold is 12.

are described in Annex F of the Work Programme General Annexes and the Online Manual.

5c. Evaluation and award: Indicative timeline for evaluation and grant agreement

described in Annex F of the Work Programme General Annexes.

6. Legal and financial set-up of the grants

Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025) [[This decision is available on the Funding and Tenders Portal, in the reference documents section for Horizon Europe, under ‘Simplified costs decisions’ or through this link: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf]].

The granting authority may, up to 4 years after the end of the action, object to a transfer of ownership or to the exclusive licensing of results, as set out in the specific provision of Annex 5.

described in Annex G of the Work Programme General Annexes.

Specific conditions

described in the [specific topic of the Work Programme]

Application and evaluation forms and model grant agreement (MGA):

Application form templates — the application form specific to this call is available in the Submission System

Standard application form (HE CSA)

Evaluation form templates — will be used with the necessary adaptations 

Standard evaluation form (HE CSA) 

Guidance

HE Programme Guide 

Model Grant Agreements (MGA)

Lump Sum MGA 

Call-specific instructions 

Detailed budget table (HE LS) 

Guidance: "Lump sums - what do I need to know?"

Additional documents:

HE Main Work Programme 2026-2027 – 1. General Introduction

HE Main Work Programme 2026-2027 – 12. Missions

HE Main Work Programme 2026-2027 – 15. General Annexes

HE Programme Guide

HE Framework Programme 2021/695

HE Specific Programme Decision 2021/764

EU Financial Regulation 2024/2509

Decision authorising the use of lump sum contributions under the Horizon Europe Programme

Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment

EU Grants AGA — Annotated Model Grant Agreement

Funding & Tenders Portal Online Manual 

Funding & Tenders Portal Terms and Conditions 

Funding & Tenders Portal Privacy Statement

Source: EU Funding & Tenders Portal · synced 2026-06-30